Company Filing History:
2 out of 2,405 
2 out of 113 Years Active: 2020-2022
Title: Sanjiv Shah: Innovator in Antibody Drug Conjugates
Introduction
Sanjiv Shah is a notable inventor based in Wakefield, MA (US). He has made significant contributions to the field of biopharmaceuticals, particularly in the development of antibody drug conjugates (ADCs). With a total of 2 patents, his work focuses on innovative solutions for anti-inflammatory applications.
Latest Patents
Sanjiv Shah's latest patents include groundbreaking technologies in the realm of antibody drug conjugates. One of his patents describes an antibody drug conjugate for anti-inflammatory applications, which comprises an antibody conjugated to an anti-inflammatory therapeutic agent via a phosphate-based linker. This linker is designed with tunable extracellular and intracellular stability, enhancing the efficacy of the therapeutic agent. Another patent focuses on phosphate-based linkers for intracellular delivery of drug conjugates. These linkers feature a monophosphate, diphosphate, triphosphate, or tetraphosphate group, along with a linker arm that includes a tuning element and optionally a spacer. The design allows for a covalent linkage of a payload to the phosphate group, ensuring targeted delivery to specific cells.
Career Highlights
Throughout his career, Sanjiv Shah has worked with prominent companies in the pharmaceutical industry. He has been associated with Merck Sharp & Dohme Corporation and Ambrx, Inc., where he has contributed to various innovative projects. His expertise in drug development has positioned him as a key player in the advancement of therapeutic technologies.
Collaborations
Sanjiv has collaborated with esteemed professionals in his field, including Robert M. Garbaccio and Jeffrey Curtis Kern. These collaborations have further enriched his research and development efforts, leading to significant advancements in biopharmaceuticals.
Conclusion
Sanjiv Shah's contributions to the field of antibody drug conjugates exemplify his innovative spirit and dedication to improving therapeutic solutions. His patents reflect a commitment to advancing medical science and enhancing patient care through targeted drug delivery systems.